| Product Code: ETC13259851 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Africa Eprescribing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Africa Eprescribing Market Overview |
3.1 Africa Regional Macro Economic Indicators |
3.2 Africa Eprescribing Market Revenues & Volume, 2021 & 2031F |
3.3 Africa Eprescribing Market - Industry Life Cycle |
3.4 Africa Eprescribing Market - Porter's Five Forces |
3.5 Africa Eprescribing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Africa Eprescribing Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.7 Africa Eprescribing Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.8 Africa Eprescribing Market Revenues & Volume Share, By Type of System, 2021 & 2031F |
3.9 Africa Eprescribing Market Revenues & Volume Share, By Usage Mode, 2021 & 2031F |
3.10 Africa Eprescribing Market Revenues & Volume Share, By Mode of Delivery, 2021 & 2031F |
3.11 Africa Eprescribing Market Revenues & Volume Share, By Substances, 2021 & 2031F |
3.12 Africa Eprescribing Market Revenues & Volume Share, By Specialties, 2021 & 2031F |
3.12 Africa Eprescribing Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 Africa Eprescribing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Africa Eprescribing Market Trends |
6 Africa Eprescribing Market, 2021 - 2031 |
6.1 Africa Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Africa Eprescribing Market, Revenues & Volume, By Solutions, 2021 - 2031 |
6.1.3 Africa Eprescribing Market, Revenues & Volume, By Services, 2021 - 2031 |
6.1.4 Africa Eprescribing Market, Revenues & Volume, By Support, 2021 - 2031 |
6.1.5 Africa Eprescribing Market, Revenues & Volume, By Implementation, 2021 - 2031 |
6.1.6 Africa Eprescribing Market, Revenues & Volume, By Training, 2021 - 2031 |
6.1.7 Africa Eprescribing Market, Revenues & Volume, By Network, 2021 - 2031 |
6.2 Africa Eprescribing Market, Revenues & Volume, By Component, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Africa Eprescribing Market, Revenues & Volume, By Hardware, 2021 - 2031 |
6.2.3 Africa Eprescribing Market, Revenues & Volume, By Software, 2021 - 2031 |
6.2.4 Africa Eprescribing Market, Revenues & Volume, By Services, 2021 - 2031 |
6.3 Africa Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Africa Eprescribing Market, Revenues & Volume, By Stand-alone E-prescribing System, 2021 - 2031 |
6.3.3 Africa Eprescribing Market, Revenues & Volume, By Integrated E-prescribing System, 2021 - 2031 |
6.4 Africa Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Africa Eprescribing Market, Revenues & Volume, By Handheld Device, 2021 - 2031 |
6.4.3 Africa Eprescribing Market, Revenues & Volume, By Computer-Based Devices, 2021 - 2031 |
6.5 Africa Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Africa Eprescribing Market, Revenues & Volume, By Web and Cloud-Based Solutions, 2021 - 2031 |
6.5.3 Africa Eprescribing Market, Revenues & Volume, By On-Premise Solutions, 2021 - 2031 |
6.6 Africa Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
6.6.1 Overview & Analysis |
6.6.2 Africa Eprescribing Market, Revenues & Volume, By Controlled Substances, 2021 - 2031 |
6.6.3 Africa Eprescribing Market, Revenues & Volume, By Non-Controlled Substances, 2021 - 2031 |
6.7 Africa Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
6.7.1 Overview & Analysis |
6.7.2 Africa Eprescribing Market, Revenues & Volume, By Oncology, 2021 - 2031 |
6.7.3 Africa Eprescribing Market, Revenues & Volume, By Sports Medicine, 2021 - 2031 |
6.7.4 Africa Eprescribing Market, Revenues & Volume, By Neurology, 2021 - 2031 |
6.7.5 Africa Eprescribing Market, Revenues & Volume, By Cardiology, 2021 - 2031 |
6.7.6 Africa Eprescribing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.8 Africa Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
6.8.1 Overview & Analysis |
6.8.2 Africa Eprescribing Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.8.3 Africa Eprescribing Market, Revenues & Volume, By Physicians, 2021 - 2031 |
6.8.4 Africa Eprescribing Market, Revenues & Volume, By Pharmacies, 2021 - 2031 |
6.8.5 Africa Eprescribing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
7 Africa Eprescribing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Africa Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.1 South Africa Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.2 Egypt Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.3 Nigeria Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Product, 2021 - 2031 |
7.3 Africa Eprescribing Market Revenues & Volume Share, By Component, 2021 & 2031F |
7.3.1 South Africa Eprescribing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.3.2 Egypt Eprescribing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.3.3 Nigeria Eprescribing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.3.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Component, 2021 - 2031 |
7.4 Africa Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
7.4.1 South Africa Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
7.4.2 Egypt Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
7.4.3 Nigeria Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
7.4.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Type of System, 2021 - 2031 |
7.5 Africa Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
7.5.1 South Africa Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
7.5.2 Egypt Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
7.5.3 Nigeria Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
7.5.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Usage Mode, 2021 - 2031 |
7.6 Africa Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
7.6.1 South Africa Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
7.6.2 Egypt Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
7.6.3 Nigeria Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
7.6.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Mode of Delivery, 2021 - 2031 |
7.7 Africa Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
7.7.1 South Africa Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
7.7.2 Egypt Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
7.7.3 Nigeria Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
7.7.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Substances, 2021 - 2031 |
7.8 Africa Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
7.8.1 South Africa Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
7.8.2 Egypt Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
7.8.3 Nigeria Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
7.8.4 Rest of Africa Eprescribing Market, Revenues & Volume, By Specialties, 2021 - 2031 |
7.9 Africa Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.9.1 South Africa Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.9.2 Egypt Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.9.3 Nigeria Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
7.9.4 Rest of Africa Eprescribing Market, Revenues & Volume, By End-User, 2021 - 2031 |
8 Africa Eprescribing Market Key Performance Indicators |
9 Africa Eprescribing Market - Export/Import By Countries Assessment |
10 Africa Eprescribing Market - Opportunity Assessment |
10.1 Africa Eprescribing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Africa Eprescribing Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 Africa Eprescribing Market Opportunity Assessment, By Component, 2021 & 2031F |
10.4 Africa Eprescribing Market Opportunity Assessment, By Type of System, 2021 & 2031F |
10.5 Africa Eprescribing Market Opportunity Assessment, By Usage Mode, 2021 & 2031F |
10.6 Africa Eprescribing Market Opportunity Assessment, By Mode of Delivery, 2021 & 2031F |
10.7 Africa Eprescribing Market Opportunity Assessment, By Substances, 2021 & 2031F |
10.8 Africa Eprescribing Market Opportunity Assessment, By Specialties, 2021 & 2031F |
10.9 Africa Eprescribing Market Opportunity Assessment, By End-User, 2021 & 2031F |
11 Africa Eprescribing Market - Competitive Landscape |
11.1 Africa Eprescribing Market Revenue Share, By Companies, 2022 |
11.2 Africa Eprescribing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here